Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7935181, 8 pages
http://dx.doi.org/10.1155/2016/7935181
Research Article

Physicochemical Characteristics of Transferon Batches

1Unidad de Desarrollo e Investigación en Bioprocesos (UDIBI), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala s/n, Colonia Santo Tomás, 11340 Ciudad de México, Mexico
2Departamento de Farmacología, Cinvestav-IPN, Avenida Instituto Politécnico Nacional 2508, Colonia San Pedro Zacatenco, 07360 Ciudad de México, Mexico
3Laboratorio de Psicoinmunología, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente, Calzada México-Xochimilco 101, Colonia San Lorenzo Huipulco, 14370 Ciudad de México, Mexico
4Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad Universitaria, 04510 Ciudad de México, Mexico
5Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala s/n, Colonia Santo Tomás, 11340 Ciudad de México, Mexico
6Unidad de Investigación, Desarrollo e Innovación Médica y Biotecnológica (UDIMEB), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala s/n, Colonia Santo Tomás, 11340 Ciudad de México, Mexico

Received 23 March 2016; Revised 27 May 2016; Accepted 14 June 2016

Academic Editor: Ali Nokhodchi

Copyright © 2016 Emilio Medina-Rivero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Salinas-Jazmin, S. Estrada-Parra, M. A. Becerril-Garcia et al., “Herpes murine model as a biological assay to test dialyzable leukocyte extracts activity,” Journal of Immunology Research, vol. 2015, Article ID 146305, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Medina-Rivero, G. Merchand-Reyes, L. Pavón et al., “Batch-to-batch reproducibility of Transferon,” Journal of Pharmaceutical and Biomedical Analysis, vol. 88, pp. 289–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Berrón-Pérez, R. Chávez-Sánchez, I. Estrada-García et al., “Indications, usage, and dosage of the transfer factor,” Revista Alergia México, vol. 54, no. 4, pp. 134–139, 2007. View at Google Scholar · View at Scopus
  4. D. Viza, H. H. Fudenberg, A. Palareti, D. Ablashi, C. De Vinci, and G. Pizza, “Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases,” Folia Biologica, vol. 59, no. 2, pp. 53–67, 2013. View at Google Scholar · View at Scopus
  5. M. Krishnaveni, “A review on transfer factor an immune modulator,” Drug Invention Today, vol. 5, no. 2, pp. 153–156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. O. Ojeda, C. Fernández-Ortega, and M. D. J. A. Rosaínz, “Dialyzable leukocyte extract suppresses the activity of essential transcription factors for HIV-1 gene expression in unstimulated MT-4 cells,” Biochemical and Biophysical Research Communications, vol. 273, no. 3, pp. 1099–1103, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Navarro Cruz, E. Serrano Miranda, S. E. P. M. Orea, L. Teran Ortiz, J. Gomez Vera, and G. Flores Sandoval, “Transference factor in moderate and severeatopic dermatitis,” Revista Alergia México, vol. 43, no. 5, pp. 116–123, 1996. View at Google Scholar
  8. G. Pizza, C. De Vinci, G. L. Conte et al., “Immunotherapy of metastatic kidney cancer,” International Journal of Cancer, vol. 94, no. 1, pp. 109–120, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Pizza, C. de Vinci, and D. Viza, “Immunotherapeutic approaches for renal cancer,” Folia Biologica, vol. 48, no. 5, pp. 167–181, 2002. View at Google Scholar · View at Scopus
  10. H. S. Lawrence, “The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes,” The Journal of Clinical Investigation, vol. 34, no. 2, pp. 219–230, 1955. View at Publisher · View at Google Scholar · View at Scopus
  11. S. J. Rozzo and C. H. Kirkpatrick, “Purification of transfer factors,” Molecular Immunology, vol. 29, no. 2, pp. 167–182, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-L. Feng, Q.-T. Liu, R.-B. Cao et al., “Characterization and immunomodulatory function comparison of various bursal-derived peptides isolated from the humoral central immune organ,” Peptides, vol. 33, no. 2, pp. 258–264, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Merchand-Reyes, L. Pavón, G. Pérez-Sánchez et al., “Swine dialyzable spleen extract as antiviral prophylaxis,” Journal of Medicinal Food, vol. 18, no. 11, pp. 1239–1246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Zhou, C. Kong, Z. Yuan et al., “Preparation, characterization, and determination of immunological activities of transfer factor specific to human sperm antigen,” BioMed Research International, vol. 2013, Article ID 126923, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Li, L. Huang, Y. Wang, X. Li, S. Liang, and Y. Zheng, “Preparation and properties of the specific anti-influenza virus transfer factor,” Head and Face Medicine, vol. 6, no. 1, article 22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. H. Kirkpatrick, “Transfer factors: identification of conserved sequences in transfer factor molecules,” Molecular Medicine, vol. 6, no. 4, pp. 332–341, 2000. View at Google Scholar · View at Scopus
  17. D. Agyei and M. K. Danquah, “Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides,” Biotechnology Advances, vol. 29, no. 3, pp. 272–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. J. Craik, D. P. Fairlie, S. Liras, and D. Price, “The future of peptide-based drugs,” Chemical Biology and Drug Design, vol. 81, no. 1, pp. 136–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Baram and M. M. Mosko, “Chromatography of the human tuberculin delayed-type hypersensitivity transfer factor,” Journal of Allergy, vol. 33, no. 6, pp. 498–506, 1962. View at Publisher · View at Google Scholar · View at Scopus
  20. A. A. Gottlieb, L. G. Foster, S. R. Waldman, and M. Lopez, “What is transfer factor?” The Lancet, vol. 302, no. 7833, pp. 822–823, 1973. View at Publisher · View at Google Scholar · View at Scopus
  21. ICH Steering Committee, Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, ICH, Geneva, Switzerland, 2000.
  22. ICH Steering Committee, Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products Q6B, ICH, 1999.
  23. U. Nirenberg, “Reversed-phase HPLC: analytical procedure,” in Peptide Analysis Protocols, B. Dun and M. Pennington, Eds., vol. 36, pp. 23–37, Humana Press, New Jersey, NJ, USA, 1996. View at Google Scholar
  24. M. Alaiz, J. L. Navarro, J. Girón, and E. Vioque, “Amino acid analysis by high-performance liquid chromatography after derivatization with diethyl ethoxymethylenemalonate,” Journal of Chromatography A, vol. 591, no. 1-2, pp. 181–186, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Clynen, G. Baggerman, S. J. Husson, B. Landuyt, and L. Schoofs, “Peptidomics in drug research,” Expert Opinion on Drug Discovery, vol. 3, no. 4, pp. 425–440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Borkowsky, P. Suleski, N. Bhardwaj, and H. S. Lawrence, “Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay,” The Journal of Immunology, vol. 126, no. 1, pp. 80–82, 1981. View at Google Scholar · View at Scopus
  27. Comisión permanente de la Farmacopea de los Estados Unidos Mexicanos, “MGA-0316. Determinación de endotoxina bacteriana,” Farmacopea de los Estados Unidos Mexicanos MGA-0316, vol. 1, México, 2011.
  28. Comisión Permanente de la Farmacopea de los Estados Unidos Mexicanos, “MGA-0571. Determinación de contenido bacteriano,” in Farmacopea de los Estados Unidos Mexicanos MGA-0571, vol. 1, 2011. View at Google Scholar
  29. Thermo Fisher Scientific, Pierce BCA Protein Assay Kit, Thermo Fisher Scientific, Hanover Park, Ill, USA, 2013.
  30. Waters, Acquity UPLC H-Class and H-Class bio Amino Acid Analysis, 2012.
  31. M. E. Hernandez, D. Mendieta, M. Pérez-Tapia et al., “Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder,” Clinical and Developmental Immunology, vol. 2013, Article ID 267871, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. C. J. Jones, S. Beni, J. F. K. Limtiaco, D. J. Langeslay, and C. K. Larive, “Heparin characterization: challenges and solutions,” Annual Review of Analytical Chemistry, vol. 4, pp. 439–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Denis, N. Brambati, B. Dessauvages et al., “Molecular weight determination of hydrolyzed collagens,” Food Hydrocolloids, vol. 22, no. 6, pp. 989–994, 2008. View at Publisher · View at Google Scholar · View at Scopus